Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) EBIT (2016 - 2025)

Cross Country Healthcare's EBIT history spans 16 years, with the latest figure at -$71.6 million for Q4 2025.

  • For Q4 2025, EBIT fell 1985.79% year-over-year to -$71.6 million; the TTM value through Dec 2025 reached -$84.4 million, down 400.53%, while the annual FY2025 figure was -$84.4 million, 400.53% down from the prior year.
  • EBIT reached -$71.6 million in Q4 2025 per CCRN's latest filing, down from -$6.0 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $90.6 million in Q1 2022 to a low of -$71.6 million in Q4 2025.
  • Average EBIT over 5 years is $21.0 million, with a median of $18.1 million recorded in 2021.
  • Peak YoY movement for EBIT: skyrocketed 7041.47% in 2021, then crashed 1985.79% in 2025.
  • A 5-year view of EBIT shows it stood at $76.0 million in 2021, then plummeted by 36.5% to $48.2 million in 2022, then crashed by 72.17% to $13.4 million in 2023, then plummeted by 125.57% to -$3.4 million in 2024, then plummeted by 1985.79% to -$71.6 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's EBIT are -$71.6 million (Q4 2025), -$6.0 million (Q3 2025), and -$5.9 million (Q2 2025).